# An Open Label, Single-arm Clinical Study Evaluating the Safety and Efficacy of ICI201 Infusion in Relapsed/Refractory Multiple Myeloma

> **NCT05980507** · PHASE1 · WITHDRAWN · sponsor: **The First Affiliated Hospital of Soochow University**

## Conditions studied

- Relapsed/Refractory Multiple Myeloma

## Interventions

- **DRUG:** ICI201

## Key facts

- **NCT ID:** NCT05980507
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-10-09
- **Primary completion:** 2023-10-18
- **Final completion:** 2023-10-18
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Molecular development strategy adjustment
- **Last updated:** 2023-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05980507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05980507, "An Open Label, Single-arm Clinical Study Evaluating the Safety and Efficacy of ICI201 Infusion in Relapsed/Refractory Multiple Myeloma". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05980507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*